This site is intended for Healthcare professionals only.

Strides Shasun gets USFDA nod for altitude sickness tablets


Strides Shasun gets USFDA nod for altitude sickness tablets

Bangalore: Strides Shasun Limited announced that it’s wholly owned subsidiary Strides Pharma Global Pte. Ltd. has received approval from the United States Food and Drug Administration (USFDA) for Acetazolamide Tablets USP, 125 mg, and 250 mg.

Acetazolamide Tablets is a generic version of Diamox Tablets.

According to IMS data, the US market for Acetazolamide Tablets is approximately USD 53 Million.

The approval, which was received in a short span of 11 months, demonstrates company’s strategy of building a niche portfolio in regulated markets, having limited competition.

The product, to be launched immediately, will be marketed by Strides Pharma Inc. in the US Market.

Acetazolamide Tablets is used to prevent and reduce the symptoms of altitude sickness.

Acetazolamide is also used with other medications to treat a certain type of eye problem (open-angle glaucoma).



Source: Press Release
0 comment(s) on Strides Shasun gets USFDA nod for altitude sickness tablets

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted